Mountain View, California-based Livongo Health, a chronic disease management company, has launched a new capability on its smart blood glucose meter. The device now employs one of the most basic – yet ...
Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company ...
Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday. The deal was wrapped up quickly, in under three months, as the companies likely look ...
CAPITAL REGION, N.Y. – BlueShield of Northeastern New York announced its expanded partnership with Livongo(R) to offer the Livongo for Diabetes program at no-cost to fully insured BlueShield members ...
In one of the biggest ever digital health deals in history, Teladoc announced Wednesday it would acquire Livongo, valuing the company at $18.5 billion. Both have experienced growth likely beyond their ...
Digital health company Livongo Health raised $20 million in Series B funding to help develop its chronic disease monitoring platform, according to a Silicon Valley Business Journal report. Livongo ...
Third quarter total revenue of $106.1 million, up 126% year-over-year Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-year “We believe the future of health is about keeping ...
Like most stocks, Livongo Health (NASDAQ: LVGO) plunged during the stock market meltdown in March. But Livongo's rebound has been more spectacular than most. Its shares are now up more than 100% year ...
The COVID-19 pandemic has accelerated the use of virtual care, and companies like Livongo stand to benefit big-time. Livongo, a chronic disease management company that has a strong focus on diabetes, ...
An unprecedented event in digital health history has taken place: the merger of two of the largest publicly traded virtual care companies, Teladoc (NYSE: TDOC) and Livongo (NDAQ: LVGO), creating the ...
After Teladoc’s massive merger with Livongo, several of the digital health startup’s top leaders will depart. Livongo President Dr. Jennifer Schneider, who held a public role with the company, and ...
Livongo's stellar Q2/2020 results are overshadowed by the announced Livongo/Teladoc merger. Livongo shareholders are seemingly getting a bad deal, and investors punished both stocks, sending them down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback